Contract 75A50124C00053
Ad Astra Diagnostics, Inc. · Department Of Health And Human Services · September 19, 2024
Ad Astra Diagnostics, Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 19, 2024 for $6.70 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Morrisville, NC. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on February 13, 2026. If all options are exercised, the contract could reach $14.31 million.
Contract details
- PIID
- 75A50124C00053
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Experimental Development
- Place of performance
- Morrisville, NC
- First action
- September 19, 2024
- Latest action
- February 13, 2026
Description
AD ASTRA DIAGNOSTICS, INC. (PLUS) &D FOR CLIA-WAIVED UBIQUITOUS EARLY SEPSIS DETECTION, SEVERITY IN AMBULANCE, PRE-HOSPITAL, POST- DISCHARGE AOI #02+: INFECTION SEVERITY AND SOLVING SEPSIS
Modification timeline
-
February 13, 2026Mod P00004 · Exercise An Option$6.70M
-
August 28, 2025Mod P00003 · Supplemental Agreement For Work Within Scope$5.00M
-
September 19, 2024Base award$5.00M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50124C00053?
Contract 75A50124C00053 is a federal contract awarded to Ad Astra Diagnostics, Inc. by Department Of Health And Human Services on September 19, 2024 for $6.70 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 2 times since the base award.
Who won contract 75A50124C00053?
Ad Astra Diagnostics, Inc. won contract 75A50124C00053 from Department Of Health And Human Services.
How much is contract 75A50124C00053 worth?
Contract 75A50124C00053 has obligated $6.70 million to date, with a total potential value of $14.31 million if all options are exercised.